Arsanis, Inc. (102) | Purchase Agreements (5)
Recent Contracts
-
Securities Purchase Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto
(Filed With SEC on July 1, 2022)
-
Securities Purchase Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
(Filed With SEC on March 3, 2022)
-
Purchase Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on January 14, 2022)
-
Securities Purchase Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
(Filed With SEC on November 5, 2021)
-
Securities Purchase Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto
(Filed With SEC on March 19, 2021)